Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Company is on track to file the Phase 3 protocol in the fourth quarter of 2025 SAN FRANCISCO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Office of Orphan ...

The FDA has approved Uplizna for generalized myasthenia gravis in adults who are anti-AChR and anti-MuSK antibody positive.

NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical ...

Key Takeaways Federal drug regulators are reportedly considering a black box warning for COVID-19 vaccinesA black box warning ...

Rafael Kramann, MD, PhD, FASN, FERA, embraced the field of nephrology early in his career for the opportunity to take on ...

Milestone announced that the FDA approved Cardamyst, a novel nasal spray designed to rapidly resolve episodes of Paroxysmal Supraventricular Tachycardia and restore sinus rhythm. ・The nasal spray can ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) to ...

SetPoint Medical, a commercial-stage medical technology company dedicated to improving care for people living with chronic ...

Privately owned, standalone infusion centers are providing an alternative to hospitals and doctors' offices for patients with ...

Mike Pence has split with President Donald Trump once again. Giving voice to anti-abortion advocates increasingly frustrated ...

Stiff person syndrome refers to a rare autoimmune neurological disorder that most commonly causes muscle stiffness and painful spasms that come and go and can worsen over time. There is currently no ...